There's no food mass to physically trap the peptide, delaying its transit
The medication's effects on appetite and satiety are mediated through central nervous system pathways, particularly in areas of the brain that regulate hunger and food intake
In summary, we provide initial real-world evidence of reduced alcohol consumption in people with obesity taking Semaglutide or Tirzepatide medications, suggesting potential efficacy for treatment in AUD comorbid with obesity. Note: Beyond what is publicly available today, several studies from established research groups showing substantial anti-addictive effects have been submitted to journals and will be published in mid-2024
However, some patients experience increased hair shedding during treatment
Vigorous agitation can damage the semaglutide peptide chains and reduce potency
Due to strong patient requests for compounded GLP-1s, we now offer a compounded oral sublingual semaglutide